Menu
GeneBe

ADORA2B

adenosine A2b receptor, the group of Adenosine receptors

Basic information

Region (hg38): 17:15945129-15975746

Links

ENSG00000170425NCBI:136OMIM:600446HGNC:264Uniprot:P29275AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ADORA2B gene.

  • Inborn genetic diseases (14 variants)
  • not provided (4 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADORA2B gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
3
missense
14
clinvar
1
clinvar
15
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 14 0 4

Variants in ADORA2B

This is a list of pathogenic ClinVar variants found in the ADORA2B region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-15945271-C-A not specified Uncertain significance (Nov 07, 2022)3090080
17-15945274-T-C not specified Uncertain significance (Jan 10, 2023)2468904
17-15945319-G-A not specified Uncertain significance (Jan 18, 2023)2476405
17-15945352-C-T Benign (Apr 10, 2018)785557
17-15945359-T-C Benign (Jun 29, 2018)716228
17-15945373-C-T not specified Uncertain significance (Dec 07, 2023)3090075
17-15945376-A-C not specified Uncertain significance (Apr 07, 2022)2320904
17-15945501-G-T not specified Uncertain significance (Feb 27, 2023)2489417
17-15945571-G-A not specified Uncertain significance (Sep 16, 2021)2250262
17-15974683-A-C not specified Uncertain significance (Apr 07, 2022)2281650
17-15974697-G-A Benign (May 24, 2018)786646
17-15974752-G-A not specified Uncertain significance (Sep 26, 2022)2314447
17-15974778-C-G not specified Uncertain significance (Jun 02, 2023)2555554
17-15974920-C-T not specified Uncertain significance (Oct 14, 2023)3090097
17-15974948-A-T not specified Uncertain significance (Mar 29, 2022)2280829
17-15974952-T-G not specified Uncertain significance (Feb 12, 2024)3090100
17-15975109-G-A not specified Uncertain significance (Jun 02, 2023)2555798
17-15975122-A-G not specified Uncertain significance (Aug 29, 2023)2622231
17-15975129-T-C Benign (Apr 10, 2018)785558
17-15975173-T-G not specified Uncertain significance (May 05, 2023)2517607
17-15975227-G-A not specified Uncertain significance (Aug 22, 2023)2594525
17-15975271-C-T not specified Uncertain significance (Feb 13, 2024)3090106
17-15975311-G-A not specified Uncertain significance (Mar 07, 2023)2495341

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ADORA2Bprotein_codingprotein_codingENST00000304222 230830
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00001770.4601257010471257480.000187
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.05521821801.010.000009142128
Missense in Polyphen5859.7130.97131790
Synonymous0.4266973.70.9370.00000359704
Loss of Function0.49089.640.8305.84e-799

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001160.000116
Ashkenazi Jewish0.000.00
East Asian0.0001090.000109
Finnish0.00004620.0000462
European (Non-Finnish)0.0002730.000273
Middle Eastern0.0001090.000109
South Asian0.0002290.000229
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Receptor for adenosine. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase.;
Pathway
Calcium signaling pathway - Homo sapiens (human);Vascular smooth muscle contraction - Homo sapiens (human);Rap1 signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Alcoholism - Homo sapiens (human);Intracellular Signalling Through Adenosine Receptor A2b and Adenosine;GPCRs, Class A Rhodopsin-like;Nucleotide GPCRs;Signaling by GPCR;Signal Transduction;Adenosine P1 receptors;Surfactant metabolism;Metabolism of proteins;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;G alpha (s) signalling events;Nucleotide-like (purinergic) receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;C-MYB transcription factor network;GPCR signaling-G alpha i;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.185

Intolerance Scores

loftool
0.607
rvis_EVS
0.64
rvis_percentile_EVS
83.9

Haploinsufficiency Scores

pHI
0.0827
hipred
Y
hipred_score
0.517
ghis
0.554

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.353

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Adora2b
Phenotype
homeostasis/metabolism phenotype; cellular phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype;

Zebrafish Information Network

Gene name
adora2b
Affected structure
hematopoietic multipotent progenitor cell
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
activation of MAPK activity;adenosine receptor signaling pathway;positive regulation of chronic inflammatory response to non-antigenic stimulus;cellular defense response;G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;activation of adenylate cyclase activity;JNK cascade;excretion;positive regulation of vascular endothelial growth factor production;positive regulation of cGMP-mediated signaling;positive regulation of guanylate cyclase activity;cellular response to extracellular stimulus;positive regulation of chemokine production;positive regulation of interleukin-6 production;positive regulation of mast cell degranulation;cellular protein metabolic process;relaxation of vascular smooth muscle;regulation of synaptic vesicle exocytosis
Cellular component
plasma membrane;integral component of plasma membrane;Schaffer collateral - CA1 synapse;glutamatergic synapse
Molecular function
G protein-coupled adenosine receptor activity